In this proposal we seek to optimize and apply HDX as an enabling technology for the functional analysis of complex biological systems, such as transcriptional complexes and G-protein coupled receptors. We will study nuclear receptor complexes, GPCRs, and the MAP kinase signaling pathway. These biological targets have been implicated in metabolic disorders, cancer, osteoporosis, immune regulation, and neurodegeneration. Although implicated in a wide range of disorders, our group and our collaborators have specific expertise in metabolic disorders, immune regulation, and Parkinson's disease. A better understanding of the mechanism of action of modulators of NRs, GPCRs and kinase signaling pathways will enable the development of more functionally selective and safer therapeutic agents. The technological aspects of this work are to optimize and apply hydrogen/deuterium exchange (HDX) to enable characterization of complex proteins such as GPCRs and large multi-protein complexes involved in the regulation of signal transduction pathways. Recently we have made several significant advances in HDX technology. Here we will build from this work and optimize methodology for the characterization of complex systems. These methods will improve on the current limits of dynamic range, protein size, and throughput. In addition, our automated system for data acquisition will be integrated with a relational database and a new suite of software tools will be further developed to facilitate seamless integration of HDX data acquisition with data management, analysis, and display. We will apply this technology to the functional analysis of nuclear receptor transcriptional complexes, S1P family receptors, and the MAP kinase JNK3. We will also demonstrate the utility of HDX technology in the context of a fully integrated high throughput screening center. Combined, these studies will raise the impact of this enabling biophysical technology on structural studies of complex biological systems.

Public Health Relevance

In this proposal we seek to optimize and apply Hydrogen/Deuterium Exchange (HDX) as an enabling technology for the functional analysis of complex biological systems such as transcriptional complexes and G-protein coupled receptors. We will study nuclear receptor complexes, GPCRs, and the MAP kinase signaling pathway. Although these targets have been implicated in a wide range of disorders, we will focus on application of the technology to metabolic disorders, immune regulation and Parkinson's disease where a better understanding of the mechanism of action of modulators of NRs, GPCRs and kinase signaling pathways will enable the development of more functionally selective and safer therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM084041-03
Application #
7991362
Study Section
Enabling Bioanalytical and Biophysical Technologies Study Section (EBT)
Program Officer
Edmonds, Charles G
Project Start
2008-12-01
Project End
2012-11-30
Budget Start
2010-12-01
Budget End
2011-11-30
Support Year
3
Fiscal Year
2011
Total Cost
$390,791
Indirect Cost
Name
Scripps Florida
Department
Type
DUNS #
148230662
City
Jupiter
State
FL
Country
United States
Zip Code
33458
Darrah, Erika; Kim, AeRyon; Zhang, Xi et al. (2017) Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis. J Proteome Res 16:355-365
Brown, Nicole E; Goswami, Devrishi; Branch, Mary Rose et al. (2015) Integration of G protein ? (G?) signaling by the regulator of G protein signaling 14 (RGS14). J Biol Chem 290:9037-49
Goswami, Devrishi; Tuske, Steve; Pascal, Bruce D et al. (2015) Differential isotopic enrichment to facilitate characterization of asymmetric multimeric proteins using hydrogen/deuterium exchange mass spectrometry. Anal Chem 87:4015-4022
Kojetin, Douglas J; Matta-Camacho, Edna; Hughes, Travis S et al. (2015) Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun 6:8013
Marciano, David P; Kuruvilla, Dana S; Boregowda, Siddaraju V et al. (2015) Pharmacological repression of PPAR? promotes osteogenesis. Nat Commun 6:7443
Lewallen, Daniel M; Sreelatha, Anju; Dharmarajan, Venkatasubramanian et al. (2014) Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. ACS Chem Biol 9:433-42
West, Graham M; Willard, Francis S; Sloop, Kyle W et al. (2014) Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain. PLoS One 9:e105683
Marciano, David P; Dharmarajan, Venkatasubramanian; Griffin, Patrick R (2014) HDX-MS guided drug discovery: small molecules and biopharmaceuticals. Curr Opin Struct Biol 28:105-11
Goswami, Devrishi; Callaway, Celetta; Pascal, Bruce D et al. (2014) Influence of domain interactions on conformational mobility of the progesterone receptor detected by hydrogen/deuterium exchange mass spectrometry. Structure 22:961-73
Boerma, Leeann J; Xia, Gang; Qui, Cheng et al. (2014) Defining the communication between agonist and coactivator binding in the retinoid X receptor ? ligand binding domain. J Biol Chem 289:814-26

Showing the most recent 10 out of 44 publications